Movember 2012 is here! It’s that time of the year again when men across the globe will chuck their razors and take pride in growing moustaches. November is the month aimed to spread awareness about men’s health issues such as prostrate and testicular cancers, and depression. What is Movember? Movember 2012 is a month-long annual event that aims to increase early cancer detection, diagnosis and effective treatments, and ultimately reduce…

More than 22,000 cases of obesity-related cancer have been reported in Britain this year, with one in 14 cases of cancer being caused by excess weight, according to figures from Cancer Research UK. Of all these cases, more than 7,750 people have breast cancer, over 5,750 have cancer of the bowels and about 2980 women have womb cancer. Obesity also increases the risk of other types of diseases including breast,…

Lily Willis, an eight-year-old brave girl had been diagnosed with bone cancer since February of this year with no hope of treatment for the ailment. But, surgeons at Newcastle’s Royal Victoria Infirmary fitted her with metal bones, which will grow along with her. Surgeons at Newcastle’s Royal Victoria Infirmary said her tumour was cancerous. The tumour was on her right leg, so her entire knee, tibia and a part of…

UK women diagnosed with advanced ovarian cancer are less likely to survive compared to women in other similar countries, according to the findings of the International Cancer Benchmarking partnership, which was set up with funding from the Department of Health. The government funded research was set up to compare cancer outcomes in a group of affluent countries around the world including Australia, Canada, Denmark and Norway.

Consuming red meat and processed meat in excess puts men at risk of esophageal cancer, says a Maastricht University study. According to a study published in Annals of Oncology, consuming red meat and processed meat is positively associated with esophageal cancer called esophageal squamous cell carcinomas in men. The study was conducted by A. P. Keszei and his colleagues at Maastricht University in Maastricht, The Netherlands. The data was gathered…

Even one glass of wine a day can trigger cancer of mouth, throat, gullet or breast, suggests a new research. Researchers from the University of Milan and other centers in the US, Canada, France, Iran and Sweden compared people who drank up to one typical drink of alcohol with people who didn’t drink at all and came to this conclusion.

The more you delay motherhood, the higher your chances of developing cancer, suggests a new study. The number of pregnant women diagnosed with cancer has increased over the past 20 years and it is believed that increased age of expectant mothers is responsible for the disturbing trend.

Ovarian cancer researchers have discovered a gene called FGF 1 that can help predict which ovarian cancer patient can benefit from chemotherapy drugs, depending on the activity levels of the gene. The FGF 1 gene is found at higher levels in cancer cells which are resistant to platinum chemotherapy treatments, a common treatment for the disease. Hence, women with high levels of FGF 1 are less likely to respond to…

Pancreatic Cancer care in the UK lacks funding in-spite of the fact that the National Cancer Institute increased its spending by 20% last year. The world’s fourth deadliest cancer reportedly takes 7900 lives in Britain every year. On account of a shortfall on funding given for pancreatic research, the survival rates have remained largely unchanged in 40 years. The main reason behind this is that the disease is only discovered…

The launch of Novartis’ breast cancer drug, Afinitor, throughout the UK offers another choice for UK patients suffering from the dreadful disease. Novartis has contended that Afinitor is the first new therapeutic method in 15 years, which presents considerable positive impact on the disease. The European Union had recently granted its endorsement for the drug to use it to treat patients with oestrogen receptor-positive (ER+), human epidermal growth factor receptor…